Non-consensual abortion drug penalties

Summary#

This bill would add a new federal crime for knowingly and intentionally giving a pregnant woman an abortion-inducing drug without her informed consent, when the drug moved in interstate or foreign commerce. It creates criminal penalties, allows civil lawsuits with damages, and adds definitions for key terms (including mifepristone and misoprostol). The bill also renames the current chapter heading from “Partial-birth abortions” to “Abortions.”

• Main change: Federal crime and penalty (up to 25 years in prison) for non-consensual administration of an abortion-inducing drug that was shipped or transported across state or national borders.
• Civil remedy: A woman can sue the person who administered, tried to administer, or conspired to administer such a drug and may get compensatory, treble statutory, and punitive damages plus attorney’s fees.
• Conspiracy/seller rule: Selling, shipping, or giving an abortion drug without taking “reasonable measures” to confirm the requester is a pregnant woman seeking an abortion is treated as conspiring to commit the offense.
• Definitions: “Abortion-inducing drug” explicitly includes mifepristone and misoprostol; “informed consent” is defined as voluntary, knowing agreement after being fully informed of nature, purpose, risks, and consequences.
• Harsher penalty if injury or death: If the woman suffers serious bodily injury or dies, an additional prison term (up to 25 years) may apply.

What it means for you#

• Pregnant people / Patients

  • If someone gives you an abortion drug without your informed consent, this bill would create a federal crime and a right to sue the person.
  • The bill does not criminalize taking an abortion drug with your informed consent.

• Health care providers and clinicians

  • Administering an abortion-inducing drug without a woman’s informed consent could lead to federal criminal charges.
  • Providers will need to document informed consent carefully to avoid liability.

• Pharmacies, online sellers, and telemedicine services

  • Selling, shipping, or mailing abortion drugs without taking “reasonable measures” to confirm the buyer is a pregnant woman seeking an abortion could be treated as a conspiracy to commit the crime.
  • This could change how vendors verify identity, pregnancy, and consent before shipping medication across state lines.

• Friends, family, caregivers, or others

  • Giving or administering an abortion drug to a woman without her voluntary, informed agreement could be a federal crime and expose you to civil suits.

• Victims seeking civil relief

  • A woman who was given such a drug without consent could sue for money damages that include compensation, treble statutory damages, punitive damages, and attorney’s fees.

• What is unclear:

  • The bill does not define what specific steps count as “reasonable measures” for sellers to verify a purchaser’s pregnancy and intent.
  • The bill does not state an effective date or explain how it would interact with state laws on abortion and criminal offenses.

Expenses#

No publicly available information.

• The bill itself does not include a fiscal note or budget estimate in the provided text.
• This could mean increased federal law enforcement and court costs if prosecutions and civil suits rise.
• It could also mean higher compliance costs for pharmacies and telemedicine providers (verification systems, recordkeeping).
• Potential civil damage awards and punitive damages could lead to financial liability for defendants, and possible increases in defense costs.

Proponents' View#

• The bill appears intended to prevent and punish forced or non-consensual abortions.
• It would create a federal enforcement path when the abortion drug was moved in interstate commerce, which can make federal authorities able to act.
• Providing a civil remedy (including treble damages and attorney’s fees) could increase compensation and deterrence for victims.
• Defining “abortion-inducing drug” to include common medications names the types of drugs the bill targets.

Opponents' View#

• One concern is the bill does not explain what counts as “reasonable measures” for sellers, leaving uncertainty for pharmacies and online providers about how to comply.
• The interstate-commerce trigger (drug moved across state lines) may reach many routine shipments, which could bring federal criminal exposure in cases that might otherwise be handled under state law.
• The risk of heavy criminal penalties and large civil damages could make vendors and clinicians more cautious, which could reduce availability of medication abortion or telemedicine services even when care is consensual.
• It is unclear how the bill would interact with existing state laws on abortion or with medical privacy rules; those interactions are not set out in the text.
• The bill does not state when it would start or set out implementation details, which could complicate enforcement and compliance planning.